BRIEF published on 09/16/2026 at 07:35, 6 hours 58 minutes ago Nicox: NCX 470 data presentation at the 2026 AAOpt Congress Phase 3 Ophthalmology Nicox NCX 470 AAOpt Congress
PRESS RELEASE published on 09/16/2026 at 07:30, 7 hours 3 minutes ago Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026 Nicox presents key data on NCX 470 at AAOpt Annual Meeting 2026, focusing on glaucoma management. Details on clinical trials and future conference participation Clinical Trials Ophthalmology Nicox NCX 470 AAOpt
BRIEF published on 09/11/2026 at 07:35, 5 days 6 hours ago Nicox's NCX 470 NDA Accepted for Review in China Ophthalmology NCX 470 Ocumension Therapeutics China Market NDA Review
PRESS RELEASE published on 09/11/2026 at 07:30, 5 days 7 hours ago Nicox Announces NCX 470 NDA in China Accepted for Review Nicox announces acceptance of NCX 470 NDA in China by NMPA for review. Regulatory decision expected 12-18 months post-submission. Details on Ocumension and NCX 470 milestones China Nicox NCX 470 Regulatory Decision NMPA
BRIEF published on 09/02/2026 at 07:35, 14 days 6 hours ago Nicox Extends Its Cash Flow Horizon Thanks to NCX 470 Ophthalmology NDA Nicox NCX 470 Cash Flow Horizon
BRIEF published on 09/02/2026 at 07:35, 14 days 6 hours ago Nicox Announces Financial Stability Extension Financial Update Ophthalmology Nicox NCX 470 Cash Runway
PRESS RELEASE published on 09/02/2026 at 07:30, 14 days 7 hours ago Nicox Announces Extension of Cash Runway Nicox extends cash runway with estimated €8.4 million as of 31 August 2026, supporting operations beyond Q1 2028. NCX 470 U.S. NDA approval milestone could fund operations into 2029 Financial Update Ophthalmology Nicox NCX 470 Cash Runway
BRIEF published on 08/27/2026 at 07:35, 20 days 6 hours ago Nicox: PDUFA date set for the NCX 470 in April 2027 FDA Glaucoma Nicox NCX 470 PDUFA
PRESS RELEASE published on 08/27/2026 at 07:30, 20 days 7 hours ago Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma Nicox announces April 2027 PDUFA date for NCX 470 in Glaucoma. Positive results from Phase 3 trials pave the way for potential FDA approval and commercial launch in H2 2027 FDA Approval Glaucoma Nicox NCX 470 PDUFA Date
BRIEF published on 08/10/2026 at 07:35, 1 month 6 days ago Nicox's NCX 470 NDA Submitted in China Nicox Glaucoma Treatment NCX 470 Ocumension China NDA
Published on 09/16/2026 at 14:00, 33 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 1 hour 3 minutes ago Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 13:23, 1 hour 10 minutes ago SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 13:15, 1 hour 18 minutes ago Impauer Technologies Announces Launch Of New Corporate Website And Provides OTC Symbol Update
Published on 09/16/2026 at 13:00, 1 hour 33 minutes ago Alaska Energy Metals Acquires 100% Of The Canwell Ni-Cu-Co-Pge Claim Block, Nikolai Nickel Project, Alaska
Published on 09/16/2026 at 14:05, 27 minutes ago Bank of Canada Selects the CanDeal Data & Analytics ("DNA") Reference Pricing Service as its pricing source for Canadian fixed income securities
Published on 09/16/2026 at 14:00, 32 minutes ago Alain de Botton joins Hakluyt's International Advisory Board
Published on 09/16/2026 at 14:00, 33 minutes ago 100 years after the Great Miami Hurricane: Florida hurricane could cause USD 300 billion or more in insured losses, finds Swiss Re Institute
Published on 09/16/2026 at 13:25, 1 hour 7 minutes ago 2026 Amos International Candy Festival Celebrates Sweet Innovation for Happiness & Health
Published on 09/16/2026 at 13:00, 1 hour 33 minutes ago TDCX Opens Lisbon Campus as Its Next European Growth Engine
Published on 09/16/2026 at 07:00, 7 hours 33 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 20 hours 33 minutes ago Report on the Combined General Meeting of the 10th of September 2026
Published on 09/15/2026 at 17:45, 20 hours 48 minutes ago EURAZEO COMPLETES THE ACQUISITION OF NETCO GROUP
Published on 09/15/2026 at 17:43, 20 hours 50 minutes ago Aéroports de Paris S.A - August 2026 traffic figures
Published on 09/15/2026 at 17:01, 21 hours 31 minutes ago Number of shares and voting rights - August 2026 (In French only)
